Type 1 diabetes mellitus imposes a significant burden of complications and mortality, despite important advances in treatment: subjects affected by this disease have also a worse quality of life-related to disease management. To overcome these challenges, different new approaches have been proposed, ...
Introduction: The expanding variety of insulins, including biosynthetic human insulin and rapid and long-acting insulin analogs, have dramatically transformed the management of type 1 diabetes (T1D) over the past 25 years. Moreover, increasing interest in the use of novel drugs developed for the ...
Type 1 diabetes cannot be cured, but it can be managed.DISCHARGE INSTRUCTIONS:Return to the emergency department if:Your child has a low blood sugar level and it does not improve with treatment. Your child's blood sugar level is above 240 mg/dL and does not come down after a dose of ...
According to the IDF, diabetes imposes a global annual economic burden of USD 966 billion in associated healthcare costs. This article will provide an update on current treatment options for type 1 and 2 diabetes and outline the latest development activities of key experimental...
Keywords: Type 1 diabetes, Autoimmunity, Personalized medicine, Personalized treatment, Genomic Risk Score, Insulin therapy, Stem cells, Gene polymorphism, Stem cells, Gene therapy, Pancreatic β cells Introduction Type 1 Diabetes (T1D) is a potentially life-threatening multifactorial autoimmune ...
There are two major types of diabetes, called type 1 and type 2. In type 1 diabetes, formerly called insulin-dependent diabetes mellitus (IDDM), or juvenile-onset diabetes mellitus, the pancreas undergoes an autoimmune attack by the body itself and is rendered incapable of making insulin. Abnor...
There are two major types of diabetes, called type 1 and type 2. In type 1 diabetes, formerly called insulin-dependent diabetes mellitus (IDDM), or juvenile-onset diabetes mellitus, the pancreas undergoes an autoimmune attack by the body itself and is rendered incapable of making insulin. Abnor...
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunot
2.2. Phase 1: Context Relevance Evaluation and Instrument Translation In August 2019, an expert panel was formed to evaluate context relevance of the DEPS-R given the current clinical and cultural context for Chinese people with T1D. The panel included an endocrinologist, two diabetes clinicians, ...
Background: Despite major medical advances, Type 1 Diabetes (T1D) patients still have greater morbimortality than the general population. Our aim was to describe our cohort of T1D patients and identify potential risk factors susceptible to prevention str